Latest Earnings Results: Q2 '26
Estimated EPS
-$0.29
Reported EPS
-$0.38
Surprise
-32.56%
Estimated Rev
$12.73M
Reported Rev
$10.88M
Surprise
-14.55%
• Reported GAAP EPS of -$0.38 down -80.95% YoY • Reported revenue of $10.88M up 18.07% YoY • ClearPoint Neuro estimates total revenue in 2026 to be between $48.0 million and $52.0 million as the company prioritizes investments in clinical case support and global regulatory product expansion initiatives.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.31 | -- | -- | N/A |
Q2 '26 | -$0.29 | -$0.38 | -32.56% | MISSED |
Q1 '26 | -$0.27 | -$0.32 | -17.07% | MISSED |
Q4 '25 | -$0.20 | -$0.26 | -30.00% | MISSED |
Q3 '25 | -$0.21 | -$0.21 | -- | EXPECTED |